Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionDillon & Associates Inc
Latest Disclosed Ownership2,508 shares
Latest Disclosed Value $ 883
Dillon & Associates Inc reports 1.01% increase in ownership of AMGN / Amgen Inc.

On May 7, 2026 - Dillon & Associates Inc filed a 13F-HR form disclosing ownership of 2,508 shares of Amgen Inc. (MX:AMGN) valued at $883 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,483 shares of Amgen Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Amgen AMGN 031162100 2,508 25 1.01 1 0.1216
2026-02-09 2025-12-31 13F Amgen COMM 031162100 2,483 0 0.00 1 0.1048
2025-10-28 2025-09-30 13F Amgen COMM 031162100 2,483 0 0.00 1 0.0900
2025-08-05 2025-06-30 13F Amgen COMM 031162100 2,483 2 0.08 1 0.0941
2025-05-12 2025-03-31 13F Amgen COMM 031162100 2,481 -180 -6.76 1 0.1150
2025-02-11 2024-12-31 13F Amgen COMM 031162100 2,661 0 0.00 1 0.0964
2024-11-05 2024-09-30 13F Amgen COMM 031162100 2,661 45 1.72 1 0.1206
2024-08-06 2024-06-30 13F Amgen COMM 031162100 2,616 0 0.00 1 0.1186
2024-04-30 2024-03-31 13F Amgen COMM 031162100 2,616 0 0.00 1 0.1167
2024-02-08 2023-12-31 13F Amgen COMM 031162100 2,616 -3 -0.11 1 0.1366
2023-11-13 2023-09-30 13F Amgen COMM 031162100 2,619 -5 -0.19 1 0.1357
2023-08-08 2023-06-30 13F Amgen COMM 031162100 2,624 0 0.00 1 0.1072
2023-05-02 2023-03-31 13F/A-1 Amgen COMM 031162100 2,624 -150 -5.41 1 0.1260
2023-05-01 2023-03-31 13F Amgen COMM 031162100 2,924 150 1 0.1147
2023-02-06 2022-12-31 13F Amgen COMM 031162100 2,774 0 0.00 1 -100.00 0.1579
2022-11-08 2022-09-30 13F Amgen COMM 031162100 2,774 0 0.00 624 -7.42 0.1447
2022-07-26 2022-06-30 13F Amgen COMM 031162100 2,774 -50 -1.77 674 -1.32 0.1519
2022-05-06 2022-03-31 13F Amgen COMM 031162100 2,824 -100 -3.42 683 3.80 0.1296
2022-02-14 2021-12-31 13F Amgen COMM 031162100 2,924 120 4.28 658 10.22 0.1147
2021-10-28 2021-09-30 13F Amgen COMM 031162100 2,804 -30 -1.06 597 -13.60 0.1144
2021-08-02 2021-06-30 13F Amgen COMM 031162100 2,834 0 0.00 691 -2.12 0.1353
2021-05-10 2021-03-31 13F Amgen COMM 031162100 2,834 -50 -1.73 706 6.49 0.1508
2021-02-12 2020-12-31 13F Amgen COMM 031162100 2,884 -100 -3.35 663 -12.53 0.1439
2020-11-06 2020-09-30 13F Amgen COMM 031162100 2,984 45 1.53 758 9.22 0.1828
2020-07-28 2020-06-30 13F Amgen COMM 031162100 2,939 -50 -1.67 694 14.33 0.1879
2020-05-07 2020-03-31 13F Amgen COMM 031162100 2,989 0 0.00 607 -15.69 0.2044
2020-02-03 2019-12-31 13F Amgen COMM 031162100 2,989 -150 -4.78 720 18.23 0.2014
2019-10-25 2019-09-30 13F Amgen COMM 031162100 3,139 0 0.00 609 5.36 0.1853
2019-07-22 2019-06-30 13F Amgen COMM 031162100 3,139 0 0.00 578 -3.02 0.1787
2019-05-07 2019-03-31 13F Amgen COMM 031162100 3,139 0 0.00 596 -2.61 0.1936
2019-02-14 2018-12-31 13F Amgen COMM 031162100 3,139 0 0.00 612 -5.85 0.2331
2018-11-14 2018-09-30 13F Amgen COMM 031162100 3,139 0 0.00 650 11.88 0.2152
2018-08-08 2018-06-30 13F Amgen COMM 031162100 3,139 -100 -3.09 581 5.44 0.2145
2018-05-08 2018-03-31 13F Amgen COMM 031162100 3,239 -300 -8.48 551 -10.55 0.2129
2018-02-08 2017-12-31 13F Amgen COMM 031162100 3,539 0 0.00 616 -6.38 0.2323
2017-11-13 2017-09-30 13F Amgen COMM 031162100 3,539 -200 -5.35 658 2.33 0.2596
2017-08-09 2017-06-30 13F Amgen COMM 031162100 3,739 0 0.00 643 4.89 0.2650
2017-04-26 2017-03-31 13F Amgen COMM 031162100 3,739 0 0.00 613 12.27 0.2610
2017-02-02 2016-12-31 13F Amgen COMM 031162100 3,739 0 0.00 546 -12.50 0.2482
2016-10-31 2016-09-30 13F Amgen COMM 031162100 3,739 0 0.00 624 9.86 0.2879
2016-08-12 2016-06-30 13F Amgen COMM 031162100 3,739 0 0.00 568 1.25 0.2609
2016-05-03 2016-03-31 13F Amgen COMM 031162100 3,739 0 0.00 561 -7.43 0.2602
2016-01-25 2015-12-31 13F Amgen COMM 031162100 3,739 0 0.00 606 17.44 0.2930
2015-10-29 2015-09-30 13F Amgen COMM 031162100 3,739 164 4.59 516 -6.35 0.2582
2015-08-07 2015-06-30 13F Amgen COMM 031162100 3,575 0 0.00 551 -3.67 0.2685
2015-04-24 2015-03-31 13F Amgen COMM 031162100 3,575 -500 -12.27 572 -11.73 0.2745
2015-02-11 2014-12-31 13F Amgen COMM 031162100 4,075 0 0.00 648 13.49 0.3148
2014-11-13 2014-09-30 13F Amgen COMM 031162100 4,075 0 0.00 571 18.96 0.2911
2014-08-14 2014-06-30 13F Amgen COMM 031162100 4,075 75 1.88 480 -2.44 0.2461
2014-05-14 2014-03-31 13F Amgen COMM 031162100 4,000 150 3.90 492 12.07 0.2631
2014-02-11 2013-12-31 13F Amgen COMM 031162100 3,850 0 0.00 439 -3.30 0.2369
2013-11-13 2013-09-30 13F Amgen COMM 031162100 3,850 0 0.00 454 19.16 0.2537
2013-08-09 2013-06-30 13F Amgen COMM 031162100 3,850 3,850 381 0.2440
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.